Last Updated: November 13, 2026

Litigation Details for Astellas Pharma Inc. v. Sawai Pharmaceutical Co. Ltd. (D. Del. 2022)

« Back to Dashboard

Astellas Pharma Inc. v. Sawai Pharmaceutical Co. Ltd. (D. Del. 2022)

Docket	1:22-cv-00818	Date Filed	2022-06-17
Court	District Court, D. Delaware	Date Terminated	2023-06-29
Cause	35:271 Patent Infringement	Assigned To	Joseph F. Bataillon
Jury Demand	None	Referred To	Christopher J. Burke
Patents	10,842,780; 6,346,532; 7,342,117; 7,982,049; 8,835,474; RE44,872
Link to Docket	External link to docket

Small Molecule Drugs cited in Astellas Pharma Inc. v. Sawai Pharmaceutical Co. Ltd.

The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial and ⤷ Start Trial .

Details for Astellas Pharma Inc. v. Sawai Pharmaceutical Co. Ltd. (D. Del. 2022)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2022-06-17				External link to document
2022-06-17	22	Stipulation-General (See Motion List for Stipulation to Extend Time)	United States Patent Nos. 6,346,532 (“the ’532 Patent”), 7,342,117 (“the ’117 Patent”), 7,982,049 (‘…(‘the ’049 Patent”), 8,835,474 (“the ’474 Patent”), RE44,872 (“the ’872 Patent”) and 10,842,780 (“the…the ’780 Patent”) (collectively, the “Patents-in-Suit”) arising out of Sawai’s submission to the Food …litigating claims of infringement involving the ’780 Patent related to Sawai’s 25 mg product in Civil Action… 17 June 2022 1:22-cv-00818 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-06-17	3	ANDA Form	Expiration Date 6,346,532 No earlier than March 27, 2022… Date of Expiration of Patents: U.S. Patent No. … Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Earlier than May 24, 2022. Date of Expiration of Patent: See Attached. Thirty Month Stay Deadline: No Earlier… ) SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG	External link to document
2022-06-17	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,346,532 ; 7,342,117 ; 7,982,049…,842,780 and RE44,872. (srs) (Attachment(s) # 1 Patent/Trademark Report) (srs). (Entered: 06/21/2022) … 17 June 2022 1:22-cv-00818 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.